Briumvi
Australian Public Assessment Report
Device/Product Name
Briumvi
Active ingredients
Ublituximab
AusPAR Date
Published
Sponsor
Submission Number
PM-2024-02503-1-1
Submission Type
New biological entity
Decision
Approved